pharmaceutical investing Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial
Pinnacle Prepares Plans for Drilling and Field Work to Follow Up on Polymetallic Discoveries at El Potrero